QVT Associates GP LLC
Insider CIK 1290166 · ACHN 10% owner · AGEN 10% owner · CNCE 10% owner · ABUS Director, 10% owner · AXON 10% owner · MYOV Director, 10% owner · UROV 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| MYOV Myovant Sciences Ltd. | P Buy | 2019-06-04 | 2019-06-06 | 2,424,242 | $8.25 | $20.00M | 40,765,599 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,752,710 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-23 | 2019-05-23 | 4,802 | $7.76 | $37.3K | 22,745,107 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-22 | 2019-05-23 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $8.52 | $85.2K | 22,735,272 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-20 | 2019-05-20 | 8,285 | $7.98 | $66.1K | 22,723,562 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-20 | 2019-05-20 | 1,715 | $8.39 | $14.4K | 22,725,277 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 22,715,277 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-16 | 2019-05-20 | 5,408 | $6.79 | $36.7K | 22,709,077 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2019-03-18 | 2019-03-19 | 6,666,667 | $1.50 | $10.00M | 105,952,381 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2018-12-18 | 2018-12-20 | 10,000,000 | $1.00 | $10.00M | 99,285,714 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2018-10-01 | 2018-10-03 | 2,678,571 | $14.00 | $37.50M | 22,703,669 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2018-06-05 | 2018-06-07 | 14,285,714 | $1.75 | $25.00M | 89,285,714 | SEC↗ |
| MYOV Myovant Sciences Ltd. | P Buy | 2018-04-02 | 2018-04-04 | 1,110,015 | $20.27 | $22.50M | 38,341,357 | SEC↗ |
| ABUS Arbutus Biopharma Corp | P Buy deriv | 2018-01-12 | 2018-01-16 | 664,000 | $100.00 | $66.40M | 1,164,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | P Buy deriv | 2017-10-16 | 2017-10-17 | 500,000 | $100.00 | $50.00M | 500,000 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 20,000 | $5.55 | $111.0K | 9,239,260 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 143,900 | $5.30 | $762.7K | 9,095,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 146,394 | $5.27 | $771.5K | 8,948,966 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 53,606 | $5.21 | $279.3K | 8,895,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 400,000 | $5.62 | $2.25M | 8,495,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 41,830 | $5.33 | $223.0K | 6,915,630 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 83,100 | $5.31 | $441.3K | 6,957,460 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 100,000 | $5.35 | $535.0K | 7,040,560 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 89,800 | $5.49 | $493.0K | 7,140,560 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 50,000 | $5.44 | $272.0K | 7,230,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 100,000 | $5.20 | $520.0K | 7,280,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 43,080 | $5.57 | $240.0K | 7,380,360 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 856,920 | $5.18 | $4.44M | 7,423,440 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2015-01-09 | 2015-01-13 | 215,000 | $5.19 | $1.12M | 8,280,360 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-16 | 2014-06-18 | 400,751 | $7.57 | $3.03M | 10,287,553 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-16 | 2014-06-18 | 150,000 | $7.81 | $1.17M | 10,037,553 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-16 | 2014-06-18 | 944,400 | $7.71 | $7.28M | 9,093,153 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-16 | 2014-06-18 | 100,000 | $7.85 | $785.0K | 10,187,553 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-16 | 2014-06-18 | 224,400 | $7.79 | $1.75M | 8,868,753 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-11 | 2014-06-12 | 36,000 | $7.71 | $277.6K | 10,688,304 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-11 | 2014-06-12 | 51,024 | $7.57 | $386.3K | 10,724,304 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-10 | 2014-06-12 | 25,200 | $7.78 | $196.1K | 10,791,753 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-10 | 2014-06-12 | 16,425 | $7.67 | $126.0K | 10,775,328 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 219,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 250,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,000,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 259,999 | — | $0 | 259,999 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 300,000 | $14.00 | $4.20M | 559,999 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-30 | 2013-12-31 | 80,439 | $3.30 | $265.4K | 10,816,953 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-27 | 2013-12-31 | 14,800 | $3.39 | $50.2K | 10,972,392 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-27 | 2013-12-31 | 75,000 | $3.38 | $253.5K | 10,897,392 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-26 | 2013-12-27 | 30,992 | $3.41 | $105.7K | 11,037,192 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-26 | 2013-12-27 | 50,000 | $3.46 | $173.0K | 10,987,192 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-24 | 2013-12-27 | 40,213 | $3.43 | $137.9K | 11,068,184 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-23 | 2013-12-24 | 75,000 | $3.30 | $247.5K | 11,140,383 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-23 | 2013-12-24 | 75,000 | $3.25 | $243.8K | 11,215,383 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-23 | 2013-12-24 | 31,986 | $3.37 | $107.8K | 11,108,397 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-20 | 2013-12-24 | 32,155 | $3.16 | $101.6K | 11,365,383 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-20 | 2013-12-24 | 75,000 | $3.16 | $237.0K | 11,290,383 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-19 | 2013-12-20 | 100,000 | $3.09 | $309.0K | 11,430,338 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-19 | 2013-12-20 | 32,800 | $3.15 | $103.3K | 11,397,538 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-18 | 2013-12-20 | 89,812 | $3.06 | $274.8K | 11,530,338 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-17 | 2013-12-18 | 42,156 | $3.08 | $129.8K | 11,620,150 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-12-16 | 2013-12-18 | 50,647 | $3.13 | $158.5K | 11,662,306 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 254,900 | $3.43 | $874.3K | 14,212,953 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 2,250,000 | $3.50 | $7.88M | 11,962,953 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 250,000 | $3.27 | $817.5K | 11,712,953 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-08-09 | 2013-08-12 | 65,982 | $6.37 | $420.3K | 14,467,853 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-08-08 | 2013-08-12 | 36,300 | $6.48 | $235.2K | 14,401,871 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-11 | 2013-07-15 | 341,355 | $6.46 | $2.21M | 14,305,909 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-11 | 2013-07-15 | 59,662 | $6.47 | $386.0K | 14,365,571 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-10 | 2013-07-11 | 90,944 | $6.38 | $580.2K | 13,964,554 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-10 | 2013-07-11 | 100,000 | $6.35 | $635.0K | 13,873,610 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-09 | 2013-07-11 | 200,000 | $6.30 | $1.26M | 13,773,610 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-08 | 2013-07-09 | 445,209 | $6.30 | $2.80M | 13,573,610 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-05 | 2013-07-09 | 72,300 | $6.21 | $449.0K | 13,128,401 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-05 | 2013-07-09 | 125,000 | $6.26 | $782.5K | 13,056,101 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-03 | 2013-07-05 | 442,737 | $6.24 | $2.76M | 12,931,101 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-03 | 2013-07-05 | 20,511 | $6.32 | $129.6K | 12,488,364 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-02 | 2013-07-05 | 1,300,000 | $6.51 | $8.46M | 12,467,853 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-02 | 2013-07-05 | 150,000 | $6.30 | $945.0K | 11,167,853 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2013-07-02 | 2013-07-05 | 50,000 | $6.31 | $315.5K | 11,017,853 | SEC↗ |